Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface

Miguel Ángel Muñoz-Alía1, Rebecca A Nace1, Lianwen Zhang1

  • 1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Insights

Measles virus (MeV) evolution is limited by its hemagglutinin glycoprotein's numerous antigenic sites, preventing immune escape. This suggests measles virus cannot easily evade vaccine-induced immunity.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Measles virus (MeV) remains a global health concern despite widespread vaccination efforts.
  • The emergence of MeV genotypes capable of evading vaccine-induced immunity has not been observed.
  • Understanding the evolutionary constraints on MeV is crucial for predicting its future behavior.

Purpose of the Study:

  • To investigate the evolutionary constraints on measles virus (MeV) hemagglutinin (H) glycoprotein.
  • To determine the impact of mutations on MeV's ability to evade serum neutralization.
  • To assess the likelihood of MeV evolving to escape vaccine-induced immunity.

Main Methods:

  • Systematic introduction of mutations into the H glycoprotein of an attenuated MeV strain.
  • Assaying serum neutralization of mutant MeV strains.
  • Analyzing the role of co-dominant antigenic sites on the H glycoprotein.
  • Identifying critical binding sites for SLAMF1 and nectin-4 receptors.

Main Results:

  • The MeV H glycoprotein possesses numerous co-dominant antigenic sites that severely constrain virus evolution.
  • Some antigenic sites are critical for binding to the SLAMF1 and nectin-4 receptors.
  • Protective neutralizing antibodies in serum target co-dominant fusion (F) glycoprotein epitopes.
  • Mutant MeV viruses retaining even one co-dominant antigenic site showed minimal reduction in serum neutralization.

Conclusions:

  • The extensive network of co-dominant antigenic sites on the MeV H and F glycoproteins significantly limits its evolutionary potential.
  • The inability of MeV to readily evolve escape mutants suggests a low likelihood of pathogenic measles virus emerging that can evade vaccine-induced immunity.
  • Current vaccination strategies remain robust against measles virus immune escape.